Abstract
Objective
EuroQol-5D (EQ-5D) and Short-Form Six-Dimensions (SF-6D) are widely used to calculate quality-adjusted life-years in cost-utility analysis. The choice of the instrument could influence the results of cost-utility analysis. Our objective was to compare the psychometric properties of the EQ-5D and SF-6D in a postoperative Spanish population, as well as assess their interchangeability in a cost-utility analysis.
Design
Ambispective study.
Setting
Tertiary public hospital.
Participants
275 Spanish patients who had undergone surgery for lumbar disc herniation.
Intervention(s)
Patients completed EQ-5D-3L and Short-Form 36 (SF-36v2) questionnaires. Internal consistency, floor and ceiling effects, agreement, and construct validity (convergent validity, including dimension-to-dimension correlations, and “known groups” validity) were assessed. The Spanish tariffs were applied.
Main outcome measure(s)
Cronbach’s α coefficient, Spearman’s rank correlation coefficient, Lin’s concordance correlation coefficient, intraclass correlation coefficient and Bland–Altman plot.
Results
Main findings were: (a) lack of agreement between EQ-5D and SF-6D utilities (Lin’s concordance correlation coefficient: 0.664 [95% CI: 0.600–0.720]; the Bland–Altman plot showed a mean difference of 0.0835 and wide limits of agreement [− 0.2602–0.4272]). (b) Lack of correlation between domains that theoretically measure similar aspects of quality of life, with the exception of “pain” domain.
Conclusions
The preference-based EQ-5D and SF-6D instruments showed valid psychometric properties to assess generic outcome in a Spanish population who had undergone surgery for lumbar disc herniation; however, utility scores derived from the measures were different. Thus, these two instruments cannot be used interchangeably to perform a cost-utility analysis, and they should both be included in sensitivity analyses.
Similar content being viewed by others
References
EuroQol Group: EuroQol—a new facility for the measurement of health-related quality of life. Health Policy 16, 199–208 (1990). https://doi.org/10.1016/0168-8510(90)90421-9
Brazier, J., Roberts, J., Deverill, M.: The estimation of a preference-based measure of health from the SF-36. J. Health Econ. 21, 271–292 (2002). https://doi.org/10.1016/S0167-6296(01)00130-8
Ware, J.E., Sherbourne, C.D.: The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 30, 473–483 (1992). https://doi.org/10.2307/3765916
Ware, J., Kosinski, M., Keller, S.D.: A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med. Care 34, 220–233 (1996)
EuroQol Research Foundation: EQ-5D-3L user guide. https://euroqol.org/docs/EQ-5D-3L-User-Guide.pdf (2018). Accessed 1 June 2018
University of Sheffield. https://www.sheffield.ac.uk/scharr/sections/heds/mvh/sf-6d/faqs (2018). Accessed 1 June 2018
Sach, T.H., Barton, G.R., Jenkinson, C., Doherty, M., Avery, A.J., Muir, K.R.: Comparing cost-utility estimates. Med. Care 47, 889–894 (2009). https://doi.org/10.1097/MLR.0b013e3181a39428
Grieve, R., Grishchenko, M., Cairns, J.: SF-6D versus EQ-5D: reasons for differences in utility scores and impact on reported cost-utility. Eur. J. Health Econ. 10, 15–23 (2009). https://doi.org/10.1007/s10198-008-0097-2
Joore, M., Brunenberg, D., Nelemans, P., Wouters, E., Kuijpers, P., Honig, A., Willems, D., De Leeuw, P., Severens, J., Boonen, A.: The impact of differences in EQ-5D and SF-6D utility scores on the acceptability of cost-utility ratios: results across five trial-based cost-utility studies. Value Health 13, 222–229 (2010). https://doi.org/10.1111/j.1524-4733.2009.00669.x
McDonough, C.M., Tosteson, A.N.A.: Measuring Preferences for cost-utility analysis. Pharmacoeconomics 25, 93–106 (2007). https://doi.org/10.2165/00019053-200725020-00003
Kontodimopoulos, N., Pappa, E., Papadopoulos, A.A., Tountas, Y., Niakas, D.: Comparing SF-6D and EQ-5D utilities across groups differing in health status. Qual. Life Res. 18, 87–97 (2009). https://doi.org/10.1007/s11136-008-9420-8
Petrou, S., Hockley, C.: An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. Health Econ. 14, 1169–1189 (2005). https://doi.org/10.1002/hec.1006
Barton, G.R., Sach, T.H., Avery, A.J., Jenkinson, C., Doherty, M., Whynes, D.K., Muir, K.R.: A comparison of the performance of the EQ-5D and SF-6D for individuals aged ≥ 45 years. Health Econ. 17, 815–832 (2008). https://doi.org/10.1002/hec.1298
Boonen, A., Van Der Heijde, D., Landewé, R., Van Tubergen, A., Mielants, H., Dougados, M., Van Der Linden, S.: How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis? Ann. Rheum. Dis. 66, 771–777 (2007). https://doi.org/10.1136/ard.2006.060384
Kwakkenbos, L., Fransen, J., Vonk, M.C., Becker, E.S., Jeurissen, M., van den Hoogen, F.H.J., van den Ende, C.H.M.: A comparison of the measurement properties and estimation of minimal important differences of the EQ-5D and SF-6D utility measures in patients with systemic sclerosis. Clin. Exp. Rheumatol. 31(2 Suppl 76), 50–56 (2013)
Mulhern, B., Meadows, K.: The construct validity and responsiveness of the EQ-5D, SF-6D and diabetes health profile-18 in type 2 diabetes. Health Qual. Life Outcomes 12, 1–10 (2014). https://doi.org/10.1186/1477-7525-12-42
Obradovic, M., Lal, A., Liedgens, H.: Validity and responsiveness of EuroQol-5 dimension (EQ-5D) versus Short Form-6 dimension (SF-6D) questionnaire in chronic pain. Health Qual. Life Outcomes 11, 1 (2013). https://doi.org/10.1186/1477-7525-11-110
Salaffi, F., Carotti, M., Ciapetti, A., Gasparini, S., Grassi, W.: A comparison of utility measurements using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 29, 661–671 (2011)
Seymour, J., McNamee, P., Scott, A., Tinelli, M.: Shedding new light onto the ceiling and floor? A quantile regression approach to compare EQ-5D and SF-6D responses. Health Econ. 19, 683–696 (2010). https://doi.org/10.1002/hec.1505
Stavem, K., Frøland, S.S., Hellum, K.B.: Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS. Qual. Life Res. 14, 971–980 (2005). https://doi.org/10.1007/s11136-004-3211-7
van Stel, H.F., Buskens, E.: Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease. Health Qual. Life Outcomes 4, 1–9 (2006). https://doi.org/10.1186/1477-7525-4-20
Whitehurst, D.G.T., Norman, R., Brazier, J.E., Viney, R.: Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises. Value Health 17, 570–577 (2014). https://doi.org/10.1016/j.jval.2014.03.1720
Wu, J., Han, Y., Zhao, F.L., Zhou, J., Chen, Z., Sun, H.: Validation and comparison of EuroQoL-5 dimension (EQ-5D) and Short Form-6 dimension (SF-6D) among stable angina patients. Health Qual. Life Outcomes 12, 1–11 (2014). https://doi.org/10.1186/s12955-014-0156-6
Brazier, J., Roberts, J., Tsuchiya, A., Busschbach, J.: A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ. 13, 873–884 (2004). https://doi.org/10.1002/hec.866
Ferreira, L.N., Ferreira, P.L., Pereira, L.N.: Comparing the performance of the SF-6D and the EQ-5D in different patient groups. Acta Med. Port. 27, 236 (2014). https://doi.org/10.1016/j.resuscitation.2012.04.001
García-Gordillo, M.Á., Del Pozo-Cruz, B., Adsuar, J.C., Cordero-Ferrera, J.M., Abellán-Perpiñán, J.M., Sánchez-Martínez, F.I.: Validation and comparison of EQ-5D-3L and SF-6D instruments in a Spanish Parkinson’s disease population sample. Nutr. Hosp. 32, 2808–2821 (2015). https://doi.org/10.3305/nh.2015.32.6.9765
Gaujoux-Viala, C., Rat, A.-C., Guillemin, F., Flipo, R.-M., Fardellone, P., Bourgeois, P., Fautrel, B.: Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohort. J. Rheumatol. 38, 1576–1584 (2011). https://doi.org/10.3899/jrheum.101006
Goodwin, P.C., Ratcliffe, J., Morris, J., Morrissey, M.C.: Using the knee-specific Hughston Clinic Questionnaire, EQ-5D and SF-6D following arthroscopic partial meniscectomy surgery: a comparison of psychometric properties. Qual. Life Res. 20, 1437–1446 (2011). https://doi.org/10.1007/s11136-011-9880-0
Huppertz-Hauss, G., Aas, E., Lie Høivik, M., Langholz, E., Odes, S., Smastuen, M., Stockbrugger, R., Hoff, G., Moum, B., Bernklev, T.: Comparison of the multiattribute utility instruments EQ-5D and SF-6D in a Europe-wide population-based cohort of patients with inflammatory bowel disease 10 years after diagnosis. Gastroenterol. Res. Pract. (2016). https://doi.org/10.1155/2016/5023973
Kanters, T.A., Redekop, W.K., Kruijshaar, M.E., van der Ploeg, A.T., Rutten-van Mölken, M.P.M.H., Hakkaart, L.: Comparison of EQ-5D and SF-6D utilities in Pompe disease. Qual. Life Res. 24, 837–844 (2015). https://doi.org/10.1007/s11136-014-0833-2
Kontodimopoulos, N., Argiriou, M., Theakos, N., Niakas, D.: The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure. Eur. J. Health Econ. 12, 383–391 (2011). https://doi.org/10.1007/s10198-010-0252-4
Dolan, P., Gudex, C., Kind, P., Williams, A.: A social tariff for EuroQol: results from a UK general population survey. Work. Pap. (1995)
Badia, X., Roset, M., Monstserrat, S., Herdman, M., Segura, A.: La versión española del EuroQol: descripción y aplicaciones. Med. Clín. 112, 79–85 (1999)
Abellán Perpiñán, J.M., Sánchez Martínez, F.I., Martínez Pérez, J.E., Méndez, I.: Lowering the “floor” on the SF-6D scoring algorithm using a lottery equivalent method. Health Econ. 21, 1271–1285 (2012). https://doi.org/10.1002/hec.1792
Leidl, R., Reitmeir, P.: A value set for the EQ-5D based on experienced health states: development and testing for the German population. Pharmacoeconomics 29, 521–534 (2011). https://doi.org/10.2165/11538380-000000000-00000
Søgaard, R., Christensen, F.B., Videbæk, T.S., Bünger, C., Christiansen, T.: Interchangeability of the EQ-5D and the SF-6D in long-lasting low back pain. Value Health 12, 606–612 (2009). https://doi.org/10.1111/j.1524-4733.2008.00466.x
Johnsen, L.G., Hellum, C., Nygaard, Ø.P., Storheim, K., Brox, J.I., Rossvoll, I., Leivseth, G., Grotle, M.: Comparison of the SF6D, the EQ5D, and the Oswestry Disability Index in patients with chronic low back pain and degenerative disc disease. BMC Musculoskelet. Disord. (2013). https://doi.org/10.1186/1471-2474-14-148
McDonough, C.M., Grove, M.R., Tosteson, T.D., Lurie, J.D., Hilibrand, A.S., Tosteson, A.N.A.: Comparison of EQ-5D, HUI, and SF-36-derived societal health state values among Spine Patient Outcomes Research Trial (SPORT) participants. Qual. Life Res. 14, 1321–1332 (2005). https://doi.org/10.1007/s11136-004-5743-2
McDonough, C.M., Tosteson, T.D., Tosteson, A.N.A., Jette, A.M., Grove, M.R., Weinstein, J.N.: A longitudinal comparison of 5 preference-weighted health state classification systems in persons with intervertebral disk herniation. Med. Decis. Mak. 31, 270–280 (2011). https://doi.org/10.1177/0272989X10380924
Fairbank, J.C., Couper, J., Davies, J.B., O’Brien, J.P.: The Oswestry low back pain disability questionnaire. Physiotherapy 66, 271–273 (1980)
University of Sheffield. https://www.shef.ac.uk/scharr/sections/heds/mvh/sf-6d (2018). Accessed 1 June 2018
Terwee, C.B., Bot, S.D.M., de Boer, M.R., van der Windt, D.A.W.M., Knol, D.L., Dekker, J., Bouter, L.M., de Vet, H.C.W.: Quality criteria were proposed for measurement properties of health status questionnaires. J. Clin. Epidemiol. 601, 34–42 (2007). https://doi.org/10.1016/j.jclinepi.2006.03.012
Cronbach, L.J.: Coefficient alpha and the internal structure of tests. Psychometrika 16, 297–334 (1951). https://doi.org/10.1007/BF02310555
Nunnally, J., Bernstein, I.: Psychometric theory. McGraw-Hill, New York (1994)
Loiacono, E.T., Watson, R.T., Goodhue, D.L.: WEBQUALTM: a measure of web site quality (2002). https://www.researchgate.net/publication/248412208_WebQual_A_Measure_of_Web_Site_Quality. Accessed 1 Sept 2018
Gliem, J., Gliem, R.: Calculating, interpreting, and reporting Cronbach’s alpha reliability coefficient for Likert-type scales. In: University, O.S. (ed.) Midwest research to practice conference in adult. Continuing and Community Education, Columbus (2003)
Ladhari, R.: Developing e-service quality scales: a literature review. J. Retail. Consum. Serv. 17, 464–477 (2010). https://doi.org/10.1016/j.jretconser.2010.06.003
McHorney, C., Tarlov, A.R.: Individual-patient monitoring in clinical practice: are available health status surveys adequate? On JSTOR. Qual. Life Res. 4, 293–307 (1995)
Andresen, E.M.: Criteria for assessing the tools of disability outcomes research. Arch. Phys. Med. Rehabil. 81, S15–S20 (2000). https://doi.org/10.1053/apmr.2000.20619
Lin, L.I.: A concordance correlation coefficient to evaluate reproducibility. Biometrics 45, 255 (1989). https://doi.org/10.2307/2532051
McBride, G.B.: A proposal for strength-of-agreement criteria for Lin’s concordance correlation coefficient. NIWA client report: HAM2005-062. (2005)
McGraw, K.O., Wong, S.P.: Forming inferences about some intraclass correlation coefficients. Psychol. Methods 1, 30–46 (1996). https://doi.org/10.1037/1082-989X.1.1.30
Koo, T.K., Li, M.Y.: A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J. Chiropr. Med. 15, 155–163 (2016). https://doi.org/10.1016/j.jcm.2016.02.012
Bland, J.M., Altman, D.G.: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1, 307–310 (1986). https://doi.org/10.1016/S0140-6736(86)90837-8
Palos, G., Mendoza, T., Mobley, G., Cantor, S., Cleeland, C.: Asking the community about cutpoints used to describe mild, moderate, and severe pain. J. Pain. 7, 49–56 (2006). https://doi.org/10.1016/j.jpain.2005.07.012
Drummond, M.: Introducing economic and quality of life measurements into clinical studies. Ann. Med. 33, 344–349 (2001). https://doi.org/10.3109/07853890109002088
O’Brien, B.J., Spath, M., Blackhouse, G., Severens, J.L., Dorian, P., Brazier, J.: A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index. Health Econ. 12, 975–981 (2003). https://doi.org/10.1002/hec.789
Walters, S.J., Brazier, J.E.: Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual. Life Res. 14, 1523–1532 (2005)
Longworth, L., Bryan, S.: An empirical comparison of EQ-5D and SF-6D in liver transplant patients. Health Econ. 12, 1061–1067 (2003). https://doi.org/10.1002/hec.787
Lamers, L.M., Bouwmans, C.A.M., van Straten, A., Donker, M.C.H., Hakkaart, L.: Comparison of EQ-5D and SF-6D utilities in mental health patients. Health Econ. 15, 1229–1236 (2006). https://doi.org/10.1002/hec.1125
Acknowledgements
The authors thank Fernando Andrés Petrel (Clinical Research Support Unit, General University Hospital of Albacete, Spain) for his invaluable help with the statistical analysis.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Selva-Sevilla, C., Ferrara, P. & Gerónimo-Pardo, M. Interchangeability of the EQ-5D and the SF-6D, and comparison of their psychometric properties in a spinal postoperative Spanish population. Eur J Health Econ 21, 649–662 (2020). https://doi.org/10.1007/s10198-020-01161-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10198-020-01161-4
Keywords
- Patient-reported outcome measure
- EuroQoL-5D (EQ-5D)
- Short-Form Six-Dimensions (SF-6D)
- Spanish version
- Psychometric properties
- Interchangeability